AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹25,141 Cr | ₹23,159 Cr | ₹21,137 Cr | ₹19,071 Cr | ₹19,441 Cr |
What is the latest Total Expenditure of AUROBINDO PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹25,141 Cr |
| Mar2024 | ₹23,159 Cr |
| Mar2023 | ₹21,137 Cr |
| Mar2022 | ₹19,071 Cr |
| Mar2021 | ₹19,441 Cr |
How is Total Expenditure of AUROBINDO PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹25,141 Cr | 8.56 | |
| Mar2024 | ₹23,159 Cr | 9.57 | |
| Mar2023 | ₹21,137 Cr | 10.83 | |
| Mar2022 | ₹19,071 Cr | -1.90 | |
| Mar2021 | ₹19,441 Cr | - | |
Compare Total Expenditure of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹91,546.1 Cr | 2.6% | -1.8% | 40.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 2.6% |
-1.8% |
40.7% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses